Terms: = Lung cancer AND DNM2, CMTDI1, 1785, ENSG00000079805, DYNII, DYN2, CMTDIB AND Treatment
3 results:
1. Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
Zhang L; Qiang P; Yu J; Miao Y; Chen Z; Qu J; Zhao Q; Chen Z; Liu Y; Yao X; Liu B; Cui L; Jing H; Sun G
Autophagy; 2019 Mar; 15(3):391-406. PubMed ID: 30145925
[TBL] [Abstract] [Full Text] [Related]
2. Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell lung cancer in the Real-World Setting in Central Europe: The INSIGHT Study.
Ramlau R; Cufer T; Berzinec P; Dziadziuszko R; Olszewski W; Popper H; Bajcic P; Dusšk L; Zbozinkova Z; Pirker R;
J Thorac Oncol; 2015 Sep; 10(9):1370-1374. PubMed ID: 26291014
[TBL] [Abstract] [Full Text] [Related]
3. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC;
Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784
[TBL] [Abstract] [Full Text] [Related]
